Saturday 17 October 2026
Export ICU’s income statement to Excel — free account
SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.2 million, up 814.1% from fiscal 2024. In the quarter to June 2026, revenue grew 82.0%, EPS grew 49.4% and free cash flow was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.90
0.16
−5.23%
Follow ICU
| Dec '17 | Jan '20 | Dec '20 | Jan '21 | Dec '21 | Jan '22 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | — | — | — | 0.00 | 0.00 |
P/S ratio |
— | — | — | — | — | — | — | — | 0.00 | 4.03 |
Altman Z-Score |
— | — | — | — | — | — | — | — | (54.71) | (16.12) |
P/FCF ratio |
— | — | — | — | — | — | — | — | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | — | — | — | — | (128.08) | (33.23) |
P/Operating CF |
— | — | — | — | — | — | — | — | (1.55) | (1.22) |
Beneish M-Score |
— | — | — | — | — | — | — | — | — | 5.00 |
P/B ratio |
— | — | — | — | — | — | — | — | 0.00 | 0.48 |
Price to Tangible BV |
— | — | — | — | — | — | — | — | 0.00 | 0.48 |
EV/Sales |
— | — | — | — | — | — | — | — | 0.00 | (3.60) |
EV/EBITDA |
— | — | — | — | — | — | — | — | 0.00 | 0.37 |
EV/Operating CF |
— | — | — | — | — | — | — | — | (0.50) | 0.33 |
EV/FCF |
— | — | — | — | — | — | — | — | (0.50) | 0.33 |
Quick Ratio |
— | 0.15 | 0.15 | 0.18 | 0.18 | 0.01 | 0.00 | 0.01 | 0.28 | 3.26 |
Current Ratio |
— | 0.15 | 0.93 | 0.19 | 0.19 | 0.57 | 0.09 | 0.18 | 0.55 | 3.63 |
Net Debt/EBITDA |
— | (16.92) | 7.38 | 0.05 | 0.06 | (0.81) | (0.67) | (0.29) | 0.10 | 0.99 |
Debt/Assets |
0.00% | 46.95% | 0.00% | 49.59% | 39.14% | 160.52% | 251.88% | 123.46% | 0.00% | 0.00% |
Debt/Equity |
— | 6.38 | 0.00 | (0.11) | (0.08) | (0.93) | (0.37) | (0.31) | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.13 |
Operating CF/Net income |
— | 21.73 | 21.73 | 1.11 | 1.11 | 0.34 | 0.64 | 0.39 | 0.64 | 1.12 |
Capex/Depreciation |
— | — | — | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
— | — | — | (190.24) | (20.99) | — | (18.43) | (13.15) | (73.12) | (392.74) |
| — | (26.26%) | (26.26%) | 0.00% | 328.73% | 0.00% | 103.40% | 151.49% | 309.35% | (295.15%) | |
| — | (3.86%) | (1.93%) | 0.00% | (1,053.89%) | 0.00% | (669.60%) | (800.85%) | (607.76%) | (129.15%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
— | 2.46% | 27.96% | 182.45% | 182.45% | 994.51% | 83.33% | 244.29% | 807.48% | (123.50%) |
Average Days of Receivables |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | 302.81 | 70.10 |
Research and Development Expense of Revenue |
— | — | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6,744.44% | 609.24% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6,571.85% | 473.10% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | — | — | 0.00% | — | 0.00% | 0.00% | 657.04% | 74.72% |
Graham Net Nets |
— | — | — | — | — | — | — | — | (0.42) | 1.98 |
Graham Number |
— | — | — | — | — | — | — | — | 101.08 | 0.00 |
Earnings Yield |
— | — | — | — | — | — | — | — | (401.03%) | (345.83%) |
Free Cash Flow Yield |
— | — | — | — | — | — | — | — | (220.62%) | (273.34%) |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.36 | 0.60 |
Operating CF per Share |
— | (0.01) | (13.14) | (0.39) | (176.34) | (0.95) | (237.62) | (118.63) | (42.80) | (6.56) |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
— | (0.01) | (13.14) | (0.39) | (176.34) | (0.95) | (237.62) | (118.63) | (42.80) | (6.56) |
Cash per Share |
— | 0.00 | 4.47 | 0.04 | 17.59 | 0.01 | 1.43 | 2.03 | 4.86 | 5.78 |
Shareholders Equity per Share |
— | 0.00 | 2.30 | (0.22) | (97.10) | (1.00) | (632.99) | (159.98) | (5.84) | 5.02 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.00 | 2.30 | (0.22) | (97.10) | (1.00) | (632.99) | (159.98) | (5.84) | 5.02 |
Free Cash Flow |
— | (0.11) | (0.11) | (5.11) | (5.11) | (7.79) | (7.79) | (10.28) | (16.01) | (13.60) |
Working Capital |
— | (0.21) | (0.02) | (2.52) | (2.52) | (2.31) | (14.63) | (10.74) | (3.07) | 9.84 |
Net Current Asset Value |
— | (0.21) | (0.02) | (2.82) | (2.82) | (9.97) | (22.28) | (15.07) | (3.07) | 9.84 |
EV/EBIT |
— | — | — | — | — | — | — | — | 0.00 | 0.36 |
Capex to Sales |
— | — | — | — | — | — | — | — | 0.00 | 0.00 |
Price to Operating Income |
— | — | — | — | — | — | — | — | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
— | — | — | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
Cash ROIC |
— | (61.21%) | (194.16%) | 254.81% | 247.05% | 1,454.10% | 59.66% | 109.92% | 4,397.53% | (60.72%) |
Accounts Receivable Turnover |
— | — | — | — | 0.00 | 0.00 | 0.00 | — | 2.18 | 7.07 |
Accounts Payable Turnover |
— | — | 0.00 | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.03 |
Inventory Turnover |
— | — | — | — | — | — | — | — | — | 0.00 |
Average Days of Payables |
— | — | 0.00 | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 6,528.68 |
Days of Inventory on Hand |
— | — | — | — | — | — | — | — | — | 454.53 |
Average Receivables |
— | — | — | — | 0.06 | 0.04 | 0.04 | — | 0.06 | 0.17 |
Average Payables |
— | — | 0.25 | — | 0.10 | — | 1.01 | 3.15 | 3.71 | 2.00 |
Average Assets |
— | 0.13 | 0.27 | 0.44 | 0.44 | 2.69 | 1.82 | 3.28 | 4.09 | 9.41 |
Average Common Equity |
— | 0.02 | 0.02 | (1.40) | (1.40) | (5.53) | (11.79) | (17.32) | (8.03) | 4.12 |
Columns are period end dates